Table 2 CGMS parameters of study participants.

From: Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring

  All (n = 123) SU group (n = 63) Non-SU group (n = 60) p-value
AG, mg/dl 138.8 ± 16.9 140.3 ± 15.7 137.2 ± 18.1 0.392
 0:00–07:00 117.1 ± 19.8 116.9 ± 29.6 117.3 ± 19.0 0.970
 07:00–24:00 147.8 ± 18.7 150.0 ± 17.1 145.5 ± 20.2 0.282
SD, mg/dl 29.4 ± 10.3 31.6 ± 11.0 27.2 ± 9.1 0.030*
 0:00–07:00 10.3 ± 5.8 11.2 ± 5.9 9.4 ± 5.6 0.028*
 07:00–24:00 28.8 ± 10.2 31.0 ± 10.8 26.5 ± 9.1 0.026*
%CV, % 21.2 ± 7.2 22.7 ± 7.8 19.8 ± 6.2 0.054
 00:00–07:00 9.1 ± 5.6 10.0 ± 6.1 8.2 ± 5.0 0.024*
 07:00–24:00 19.4 ± 6.3 20.6 ± 6.7 18.2 ± 5.6 0.051
Maximum glucose, mg/dl 216.4 ± 38.1 223.8 ± 36.2 208.7 ± 38.7 0.020*
Minimum glucose, mg/dl 92.0 ± 20.6 91.0 ± 21.7 93.0 ± 19.6 0.767
LAGE, mg/dl 124.4 ± 40.1 132.7 ± 41.2 115.7 ± 37.2 0.020*
MPPGE, mg/dl 65.9 ± 26.0 68.8 ± 25.4 62.8 ± 26.5 0.125
 Morning 80.9 ± 35.9 86.3 ± 36.4 75.1 ± 34.7 0.069
 Noon 46.3 ± 28.4 45.1 ± 29.8 47.6 ± 26.9 0.622
 Evening 70.4 ± 37.0 74.8 ± 35.8 65.9 ± 38.0 0.242
LBGI 1.20 ± 2.90 1.05 ± 1.82 1.35 ± 3.72 0.736
HBGI 6.98 ± 6.21 7.46 ± 6.59 6.48 ± 5.79 0.392
Time above range, > 180 mg/dl, % 12.0 ± 9.6 13.3 ± 9.3 10.6 ± 9.9 0.111
Time in range, 70–180 mg/dL % 87.2 ± 9.8 85.7 ± 9.5 88.8 ± 9.9 0.077
Time below range, < 70 mg/dl, % 0.77 ± 2.43 0.97 ± 2.89 0.56 ± 1.83 0.487
Time below range, < 54 mg/dL, % 0.11 ± 0.61 0.22 ± 0.84 0 0.048*
Presence of TBR < 70, n (%) 17 (13.8) 10 (15.9) 7 (11.7) 0.457
Presence of TBR < 54, n (%) 4 (3.3) 4 (6.4) 0 (0) 0.119
  1. Data are mean ± SD. P values are for the differences between the SU and non-SU groups.
  2. *p < 0.05 by Mann–Whitney’s U test.